S&P 500   4,309.44 (+0.23%)
DOW   33,633.66 (-0.10%)
QQQ   360.58 (+0.72%)
AAPL   172.00 (+0.77%)
MSFT   318.13 (+1.43%)
META   306.15 (+0.72%)
GOOGL   132.20 (-0.08%)
AMZN   127.98 (+1.59%)
TSLA   252.28 (+2.39%)
NVDA   437.75 (+1.59%)
NIO   9.05 (+1.57%)
BABA   87.16 (+1.89%)
AMD   104.13 (+1.33%)
T   15.01 (+0.00%)
F   12.59 (+0.24%)
MU   68.23 (+4.65%)
CGC   0.81 (-1.00%)
GE   110.68 (-1.48%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.88 (+2.46%)
PYPL   58.76 (+1.00%)
NFLX   378.63 (+0.60%)
S&P 500   4,309.44 (+0.23%)
DOW   33,633.66 (-0.10%)
QQQ   360.58 (+0.72%)
AAPL   172.00 (+0.77%)
MSFT   318.13 (+1.43%)
META   306.15 (+0.72%)
GOOGL   132.20 (-0.08%)
AMZN   127.98 (+1.59%)
TSLA   252.28 (+2.39%)
NVDA   437.75 (+1.59%)
NIO   9.05 (+1.57%)
BABA   87.16 (+1.89%)
AMD   104.13 (+1.33%)
T   15.01 (+0.00%)
F   12.59 (+0.24%)
MU   68.23 (+4.65%)
CGC   0.81 (-1.00%)
GE   110.68 (-1.48%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.88 (+2.46%)
PYPL   58.76 (+1.00%)
NFLX   378.63 (+0.60%)
S&P 500   4,309.44 (+0.23%)
DOW   33,633.66 (-0.10%)
QQQ   360.58 (+0.72%)
AAPL   172.00 (+0.77%)
MSFT   318.13 (+1.43%)
META   306.15 (+0.72%)
GOOGL   132.20 (-0.08%)
AMZN   127.98 (+1.59%)
TSLA   252.28 (+2.39%)
NVDA   437.75 (+1.59%)
NIO   9.05 (+1.57%)
BABA   87.16 (+1.89%)
AMD   104.13 (+1.33%)
T   15.01 (+0.00%)
F   12.59 (+0.24%)
MU   68.23 (+4.65%)
CGC   0.81 (-1.00%)
GE   110.68 (-1.48%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.88 (+2.46%)
PYPL   58.76 (+1.00%)
NFLX   378.63 (+0.60%)
S&P 500   4,309.44 (+0.23%)
DOW   33,633.66 (-0.10%)
QQQ   360.58 (+0.72%)
AAPL   172.00 (+0.77%)
MSFT   318.13 (+1.43%)
META   306.15 (+0.72%)
GOOGL   132.20 (-0.08%)
AMZN   127.98 (+1.59%)
TSLA   252.28 (+2.39%)
NVDA   437.75 (+1.59%)
NIO   9.05 (+1.57%)
BABA   87.16 (+1.89%)
AMD   104.13 (+1.33%)
T   15.01 (+0.00%)
F   12.59 (+0.24%)
MU   68.23 (+4.65%)
CGC   0.81 (-1.00%)
GE   110.68 (-1.48%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.88 (+2.46%)
PYPL   58.76 (+1.00%)
NFLX   378.63 (+0.60%)

Inari Medical (NARI) Stock Forecast, Price & News

$66.31
-0.37 (-0.55%)
(As of 12:21 PM ET)
Compare
Today's Range
$65.95
$67.25
50-Day Range
$55.60
$71.67
52-Week Range
$52.59
$83.84
Volume
78,348 shs
Average Volume
780,607 shs
Market Capitalization
$3.80 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$85.25

Inari Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.83 Rating Score
Upside/​Downside
27.8% Upside
$85.25 Price Target
Short Interest
Healthy
8.59% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.89mentions of Inari Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$8.43 M Sold Last Quarter
Proj. Earnings Growth
725.00%
From $0.04 to $0.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.62 out of 5 stars

Medical Sector

394th out of 970 stocks

Surgical & Medical Instruments Industry

51st out of 101 stocks


NARI stock logo

About Inari Medical (NASDAQ:NARI) Stock

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

NARI Price History

NARI Stock News Headlines

CFO Mitch Hill Sells 6,500 Shares of Inari Medical Inc
Better Than Oil Stocks?
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment.
Inari Medical (NARI) Receives a Hold from Truist Financial
The Next Best AI Stock to Watch After Nvidia
This emerging NASDAQ company may be the best AI stock to watch in the AI boom.
Why Shares of Inari Medical Are Up Thursday
Inari Medical earnings: here's what Wall Street expects
NARI Inari Medical, Inc.
See More Headlines
Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Company Calendar

Last Earnings
8/02/2023
Today
9/29/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
1,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$85.25
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$65.00
Forecasted Upside/Downside
+27.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

Net Income
$-29,270,000.00
Pretax Margin
-2.80%

Debt

Sales & Book Value

Annual Sales
$383.47 million
Book Value
$7.77 per share

Miscellaneous

Free Float
50,527,000
Market Cap
$3.82 billion
Optionable
Not Optionable
Beta
1.00
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Andrew J. HykesMr. Andrew J. Hykes (Age 49)
    CEO, Pres & Director
    Comp: $863.78k
  • Mr. Mitchell C. HillMr. Mitchell C. Hill (Age 64)
    Chief Financial Officer
    Comp: $811.08k
  • Dr. Thomas M. Tu M.D. (Age 50)
    Chief Medical Officer
    Comp: $812.94k
  • Mr. Paul A. Koehn (Age 60)
    Sr. VP of Operations
  • Mr. John Hsu C.F.A.
    VP of Investor Relations
  • Ms. Angela Ahmad
    Gen. Counsel & Sec.
  • Mr. Eric Khairy
    Sr. VP of Marketing
  • Mr. John R. Borrell (Age 56)
    Sr. VP of Sales
  • Ms. Tara Dunn
    Sr. VP of Clinical Affairs & Market Devel.
  • Mr. Brian Strauss
    Sr. VP of Engineering













NARI Stock - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NARI shares.
View NARI analyst ratings
or view top-rated stocks.

What is Inari Medical's stock price forecast for 2023?

6 brokerages have issued 1-year price objectives for Inari Medical's shares. Their NARI share price forecasts range from $65.00 to $100.00. On average, they anticipate the company's share price to reach $85.25 in the next twelve months. This suggests a possible upside of 27.8% from the stock's current price.
View analysts price targets for NARI
or view top-rated stocks among Wall Street analysts.

How have NARI shares performed in 2023?

Inari Medical's stock was trading at $63.56 at the beginning of the year. Since then, NARI stock has increased by 4.9% and is now trading at $66.68.
View the best growth stocks for 2023 here
.

When is Inari Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our NARI earnings forecast
.

How were Inari Medical's earnings last quarter?

Inari Medical, Inc. (NASDAQ:NARI) issued its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.14) by $0.18. The business earned $119.01 million during the quarter, compared to the consensus estimate of $116.67 million. Inari Medical had a negative net margin of 3.66% and a negative trailing twelve-month return on equity of 3.80%. Inari Medical's revenue for the quarter was up 28.3% on a year-over-year basis. During the same period in the previous year, the business posted ($0.19) earnings per share.

What guidance has Inari Medical issued on next quarter's earnings?

Inari Medical issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $482.00 million-$492.00 million, compared to the consensus revenue estimate of $483.82 million.

What other stocks do shareholders of Inari Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?

(NARI) raised $110 million in an initial public offering on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

What is Inari Medical's stock symbol?

Inari Medical trades on the NASDAQ under the ticker symbol "NARI."

How do I buy shares of Inari Medical?

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inari Medical's stock price today?

One share of NARI stock can currently be purchased for approximately $66.68.

How much money does Inari Medical make?

Inari Medical (NASDAQ:NARI) has a market capitalization of $3.82 billion and generates $383.47 million in revenue each year. The company earns $-29,270,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis.

How many employees does Inari Medical have?

The company employs 1,100 workers across the globe.

How can I contact Inari Medical?

Inari Medical's mailing address is 9 Parker Suite 100, Irvine CA, 92618. The official website for the company is www.inarimedical.com. The company can be reached via phone at 877-923-4747 or via email at ir@inarimedical.com.

This page (NASDAQ:NARI) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -